| References |
1. Eby GA, Davis DR, Halcomb WW. Reduction in duration of common colds by zinc gluconate lozenges in a double blind study. Antimicrob Agents Chemother 1984;25:20-24.
2. Al-Nakib W, Higgins PG, Barrow I, Batstone G, Tyrrell DAJ. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges. J Antimicrob Chemother 1987;20:893-901.
3. Potter YJ, Hart LL. Zinc lozenges for treatment of common colds. Ann Pharmacother 1993;27:589-592.
4. Johnston SL, Sanderson G, Pattemore PK, Smith S, Bardin PG, Bruce CB et al. Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol 1993;31:111-117.
5. Korant BD, Kaurer JC, Butterworth BE. Zinc ions inhibit replication of rhinoviruses. Nature 1974;248:588-590.
6. Korant BD, Butterworth BE. Inhibition by zinc of rhinovirus protein cleavage: interaction of zinc with capsid polypeptides. J Virol 1976;18:298-306.
7. Butterworth BE, Grunert RR, Korant BD, Lonberg-Holm K, Yin FH. Replication of rhinoviruses. Arch Virol 1976;51:169-189.
8. Korant BD. Role of cellular and viral proteases in the processing of picornavirus proteins. In: Perez-Bercoff R, ed. The molecular biology of picornaviruses. New York: Plenum Publishing, 1979:149-173.
9. Butterworth BE, Korant BD. Characterization of the large picornaviral polypeptides produced in the presence of zinc ion. J Virol 1974;14:282-291.
10. Merluzzi VJ, Cipriano D, McNeil D, Fuchs V, Supeau C, Rosenthal AS, et al. Evaluation of zinc complexes on the replication of rhinovirus 2 in vitro. Res Commun Chem Pathol Pharmacol 1989;66:425-440.
11. Geist FC, Bateman JA, Hayden FG. In vitro activity of zinc salts against human rhinoviruses. Antimicrob Agents Chemother 1987;31:622-624.
12. Pasternak CA. A novel form of host defense: membrane protection by calcium and zinc ions. Biosci Rep 1987;7:81-91.
13. Osol A. Astringents and antiperspirants. In: Osol A. ed. Remington's pharmaceutical sciences, 16th ed. Easton: Mack Publishing Co, 1980:720-723.
14. Sugarman B. Zinc and infection. Rev Infect Dis 1983;5:137-147.
15. Bashford CL, Alder GM, Menestrina G, Micklem KJ, Murphy JJ, Pasternak CA. Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents - a common mechanism blocked by divalent cations. Biol Chem 1986;261:9300-9308.
16. Bashford CL, Menestrina G, Henkart PA, Pasternak CA. Cell damage by cytolysin. J Immunol 1988;141:3965-3974.
17. Bashford CL, Alder GM, Graham JM, Menestrina G, Pasternak CA. Ion modulation of membrane permeability: effect of cations on intact cells and on cells and phospholipid bilayers treated with pore-forming agents. J Membr Biol 1988;103:79-94.
18. Pasternak CA. Virus, toxin, complement: common actions and their prevention by Ca2+ or Zn2+. Bioessays 1987;6:14-19.
19. Norris D. Zinc and cutaneous inflammation. Arch Dermatol 1985;121:985-989.
20. Chvapil M, Stankova L, Weldy P, Bernhard D, Campbell J, Carlson EC, et al. The role of zinc in the function of some inflammatory cells. In: Zinc metabolism: Current aspects in health and disease. New York: Alan R. Liss, Inc, 1977:103-122.
21. Reardon CL, Lucas DO. Zn2+ -and Hg2+ -mediated induction of mitogenesis, cell-mediated cytotoxicity, and interferon production in murine lymphocytes. In: Parker JW, O'Brian RL, eds. Proceedings of the Fifteenth Leucocyte Culture Conference. New York: John Wiley and Sons, Inc, 1983:449-462.
22. Reardon CL, Lucas DO. Heavy metal mitogenesis: Zn2+ and Hg2+ induce cellular cytotoxicity and interferon production in murine T lymphocytes. Immunobiology 1987;175:455-469.
23. Salas M, Kirchner H. Induction of interferon-gamma in human leukocyte cultures stimulated by Zn2+. Clin Immunol Immunopathol 1987;45:139-142.
24. Gupta D, Ho PS. Some formal aspects of diffusion. In: Gupta D, Ho PS, eds. Diffusion Phenomena in Thin Films and Microelectronic Materials. Park Ridge, NJ: Noyes Publications, 1988;1-16.
25. Eby GA. Handbook for curing the common cold - the zinc lozenge story. Austin: George Eby Research, 1994:1-103.
26. Adler S, Fraley DS. Acid-base regulation, cellular and whole body. In: Arieff AI, DeFronzo RA, eds. Fluid, electrolyte, and acid-base disorders. New York: Churchhill Livingstone, 1985:1:221-257.
27. Guyton AC. Regulation of acid-base balance. In: Textbook of medical physiology. New York: W. B. Saunders Co., 1986:438-451.
28. Eby GA. The zinc lozenge and common cold story. In: Berthon G, ed. Handbook of Metal-Ligand Interactions in Biological Fluids, 2: Bioinorganic Medicine, Volume 2. New York: Marcel Dekker, Inc., 1995.
29. Briggs J, Finch P, Matulewicz M C, Weigel H. Complexes of copper(II), calcium, and other metal ions with carbohydrates: Thin-layer ligand-exchange chromatography and determination of relative stabilities of complexes. Carbohydr Res 1981;97:181-188.
30. Gwaltney JM Jr. Rhinovirus. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and practices of infectious diseases. New York:John Wiley & Sons; 1979; 1124-1134.
31. Smith DS, Helzner EC, Nuttall CE Jr, Collins M, Rofman BA, Ginsberg D, et al. Failure of zinc gluconate in treatment of acute upper respiratory tract infections. Antimicrob Agents Chemother 1989;33:646-648.
32. Weismann K, Jakobsen JP, Weismann JE, Hammer UM, Nyholm SM, Hansen B, et al. Zinc gluconate for common cold. Dan Med Bull 1990;37:279-281.
33. Douglas RM, Miles HB, Moore BW, Ryan P, Pinnock CB. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infections in Australian adults. Antimicrob Agents Chemother 1987;31:1263-1265.
34. Godfrey JC, Conant Sloane B, Smith DS, Turco JH, Mercer N, Godfrey NJ. Zinc gluconate and the common Cold: a controlled clinical study. J Int Med Res 1992;20:234-246.
35. Farr BM, Conner EM, Betts RF, Oleske J, Minnefor A, Gwaltney JM, Jr. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother 1987;31:1183-1187.
36. Nordenström BE. Biologically closed electric circuits: Clinical, experimental and theoretical evidence for an additional circulatory system. Stockholm: Nordic Medical Publications, 1983:112-172.
37. Tucci ER, Ke CH, Li NC. Linear free energy relationships for proton dissociation and metal complexation of pyrimidine acids. J Inorg Nucl Chem 1967;29:1657-1667.
38. Berthon G, Germonneau P. Histamine as a ligand in blood plasma. Part 6. Aspartate and glutamate as possible partner ligands for zinc and histamine to favour histamine catabolism. Agents Actions 1982;12:619-629.
39. Martin RB. pH as a variable in free zinc ion concentration from zinc-containing lozenges (letter). Antimicrob Agents Chemother 1988;32:608-609.
40. Berthon G, May PM, Williams DR. Computer simulation of metal-ion equilibria in biofluids. Part 2. Formation constants for zinc(II)-citrate-cysteinate binary and ternary complexes and improved models of low-molecular-weight zinc species in blood plasma. J Chem Soc, Dalton Trans 1978;1433-1438.
41. Hacht B, Berthon G. Metal ion-FTS nonapeptide interactions. A quantitative study of zinc(II)-nonapeptide complexes (thymulin) under physiological conditions and assessment of their biological significance. Inorg Chim Acta 1987;136:165-171.
42. Berhon G, Varsamidis A, Blaquiere C, Rigal D. Histamine as a ligand in blood plasma. Part 7. Malate, malonate, maleate and tartrate as adjuvants of zinc to flavor histamine tissue diffusion through mixed-ligand cordination. In vitro tests on lymphocyte proliferation. Agents Actions 1987;22:231-247.
43. Alemdaroglu T, Berthon G. Trace metal requirements in total parenteral nutrition II. Potentiometric study of the metal-ion equilibria in the zinc-histidine, zinc-glycine, zinc-cysteine-histinidine, zinc-glycine-histidine and zinc-glycine-cysteine systems under physiological conditions. J Electroanal Chem Interfacial Electrochem 1981;128:49-62.
44. Cunnane SC. Zinc: Clinical and Biochemical Significance. Boca Raton, FL: CRC Press;1988:65-66.
45. Cannan RK, Kibrick A. Complex formation between carboxylic acids and divalent metal cations. J Amer Chem Soc 1938;60:2314-2320.
46. Furia TE. Sequestrants in food. In Furia T.E. ed., CRC handbook of food additives. 2nd ed. West Palm Beach, Fl: CRC Press, 1972:271-294.
47. Zinc acetate. Eds: Windholz M, Budavari S, Blumetti RF, Otterbein ES. The Merck index. Rahway NJ: Merck & Co., 1983:1455.
48. Struckhoff G, Heymann E. Rat peritoneal mast cells release dipeptidyl peptidase II. Biochem J 1986;236:215-219.
49. Marone G, Findley SR, Lichtenstein LM. Modulation of basophil histamine release by zinc. J Allergy Clin Immunol 1979;65:171.
50. Eby GA, inventor. Flavor stable zinc acetate compositions for oral absorption. US patent 5,095,035. 1992, Mar 10.
51. Eby GA, inventor. Flavor stable zinc acetate compositions for oral absorption. International patent application PCT/US91/09487. 1991, Dec 17.
52. Eby GA, inventor. Cure for common cold. US patent 5,409,905. 1995, Apr 25.